Barclays Raises Oracle Price Target to $240

Analyst: Raimo Lenschow 1 min read Reproduced verbatim
Rating
Overweight
Target
$240
from $230 (+4%)
Outcome
Reached
on June 1, 2026

Barclays’s latest target on Oracle is now $252 (Sep 11, 2026); the median of 23 firms is $240. Barclays has reached 82% of its year-old targets (44 scored).

Barclays and Oracle logos

What the analyst said

Barclays analyst Raimo Lenschow raised the price target on Oracle (NYSE: ORCL) to $240.00 (from $230.00) while maintaining an Overweight rating.

“Last year, when Oracle shares hit all-time highs on the back of the large announced AI contracts there was little detail available and the excitement just came from the large RPO numbers. The past few months were a lot tougher as investors worried about what all could go wrong in terms of customer concentration, ability to finance the necessary CapEx, management’s ability to deliver on these contracts, the gross margin profile of these contracts, etc. We do understand that investors need to ask all these questions but we also have to acknowledge that we are getting more and more answers.

We already got the financing announcement in recent weeks, the new financing round for OpenAI and ORCL’s continued bookings strength is reducing the customer risk and this quarter addressed the CapEx (no negative upside surprises), GM (a 32% base rate for AI infra this quarter) and execution questions (raised guidance from more data center capacity becoming operational as planned).

In other words, with fundamentals becoming more visible, we can start looking at fundamental valuations again. The ~16x PE ratio (CY27) for a company that will grow revenue and earnings over 30% in the coming years seems very attractive to us and we maintain our Overweight rating and raise our price target to $240 (from $230).”

Cite this note: Price Target, "Barclays Raises Oracle Price Target to $240," March 11, 2026. https://price-target.com/2026/03/11/170204/
Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

ORCL trades at $101. The 23 analysts who set a target in the last 3 months range from $155 to $400, with a median of $240. This $240 target is in line with the median.

Since the note ORCL has moved −32% (from $149). 12-month window: day 255 of 365, closes on March 11, 2027.

Track record

This call✓ Target reached on June 1, 2026, 3 months after the note.

Firm track recordBarclays: 82% of its 44 targets at least a year old were reached within 12 months (#9 of 29 firms). Accuracy ranking →

Earnings reactionOne of 16 notes after Oracle’s Mar 10 results: 4 raised · 2 cut · 8 kept. See every call →

Barclays on Oracle

Barclays price targets on Oracle

6 calls from February 2, 2026 to September 11, 2026. The target went from $310 to $252 (−19%). The rating stayed Buy.

Barclays targetORCL share price
  1. September 11, 2026Target raised from $250 (+1%)Buy$252
  2. June 11, 2026Target raised from $240 (+4%)Buy$250
  3. June 8, 2026Kept the $240 targetBuy$240
  4. March 11, 2026 This noteTarget raised from $230 (+4%)Buy$240
  5. March 9, 2026Target cut from $310 (−26%)Buy$230
  6. February 2, 2026Earliest call shownBuy$310
Share Reddit StockTwits
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.